Related Experiment Videos
Genetic and cellular basis of multistep carcinogenesis
1Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709.
Pharmacology & Therapeutics
|January 1, 1990
Summary
Cancer develops through multiple genetic and epigenetic changes, involving oncogenes and tumor suppressor genes. This multistep process, observed in vivo and in vitro, is crucial for neoplastic progression in various models, including human tumors.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cancer development is a complex, multistep process requiring multiple genetic alterations.
- These alterations affect key genes, including oncogenes and tumor suppressor genes, driving neoplastic transformation.
Purpose of the Study:
- To elucidate the genetic and epigenetic events underlying cancer development.
- To dissect the multistep process of neoplastic progression at cellular and molecular levels.
Main Methods:
- In vivo studies using various animal models to define cancer development stages (initiation, progression).
- In vitro studies using cell culture systems, specifically the Syrian hamster embryo cell model, for detailed molecular analysis.
- Analysis of genetic events in human tumors to compare with experimental models.
Main Results:
- Neoplastic progression in the Syrian hamster embryo cell model requires four heritable changes: activation of two oncogenes and loss of two tumor suppressor genes.
- Both genetic and epigenetic events are integral to the stages of cancer development.
- Experimental findings suggest the multistep paradigm and similar genetic events are relevant to human cancer development.
Conclusions:
- Cancer arises from a series of accumulating genetic and epigenetic alterations.
- The multistep model of cancer development, involving oncogene activation and tumor suppressor gene loss, is supported by experimental and preliminary human tumor data.
- Understanding these genetic changes is fundamental to comprehending cancer etiology and progression.